Professor Adrian Thrasher is a world-leading pioneer in the field of human gene therapy. He was one of the first international scientists to develop techniques for clinical gene transfer to bone marrow stem cells, that has led to curative treatments for inherited disorders of immunity and metabolism. The application of these transformative therapies has emerged over three decades from small academic trials to major commercial interests. He was scientific co-founder of Orchard Therapeutics, which is now established as a global gene therapy leader for rare diseases. In addition to his pre-eminence in gene-therapy, he has an outstanding track record in basic research into biological mechanisms and the aetiology of human disease, particularly inherited immunodeficiency.
